Digital health in LMICs—finding opportunities for a double bottom line

By Skye Gilbert, Executive Director, Digital Square at PATH “So you want private capital to invest in a suite of interchangeable, interoperable digital health products for low middle-income country markets, but your problem statement is ‘context-specific’, your product is ‘multi-faceted’ and your market size is ‘unquantified’.” My brilliant friend, a former hedge fund partner now doing a startup, is trying … Read More

Matt RomneyDigital health in LMICs—finding opportunities for a double bottom line

Interviews: Leveraging business models for social good: An Insider Look at CSR

There are any number of way to define Corporate Social Responsibility (CSR). For the purpose of this article we are referring to efforts made by companies aimed at making some sort of social or environmental impact. It is a way for companies to attract consumers and employees while also giving back to society. CSR picked up at the turn of … Read More

Alyssa GovindanInterviews: Leveraging business models for social good: An Insider Look at CSR

Applications Open for Second Round of 2016 GBCHealth Business Action on Health Awards

Applications are now open for the 2016 GBCHealth Business Action on Health Awards in the categories of: Partnerships for Global Health, Community Programs—Focus on Global Health Security, and Workforce & Workplace Engagement. Apply now and share with your networks. The GBCHealth Business Action on Health Awards honor companies that exemplify a spirit of innovation and dedication to outstanding achievements in global … Read More

Nisa PatelApplications Open for Second Round of 2016 GBCHealth Business Action on Health Awards

Spotlight on PSD Members – Eli Lilly, Johnson & Johnson, Sumitomo Chemical and Sanofi

In honor of World TB Day and World Malaria Day, we are highlighting some of the extraordinary work the PSD member companies are undertaking in the fight to end these epidemics. Read more about how Eli Lilly is bringing global attention to the TB-diabetes co-epidemic, Janssen’s partnership to expand access to a new MDR-TB drug, Sumitomo Chemical’s commitment to protect … Read More

Nisa PatelSpotlight on PSD Members – Eli Lilly, Johnson & Johnson, Sumitomo Chemical and Sanofi

Three ways business can help achieve the SDGs

Authors: Nancy Wildfeir-Field, John Simon and Suprotik Basu. This article originally appeared on the World Economic Forum’s Global Agenda blog on February 11, 2016. The Millennium Development Goals (MDGs) have mobilized the most successful anti-poverty movement in history. Yet in 2016, we still find ourselves in a situation where millions of families have been left behind. With the launch of … Read More

Nisa PatelThree ways business can help achieve the SDGs

Perspectives On A New Strategy to Shape Markets for Health Products

The Private Sector constituency has been an active participant in the Global Fund’s recent initiative to revise its Market Shaping Strategy (MSS). The Global Fund is one of the largest procurers of health-related commodities in the world, and as a result of this purchasing power inevitably shapes the markets in which it operates. Recognition of this market shaping power led … Read More

Nisa PatelPerspectives On A New Strategy to Shape Markets for Health Products

Business Leaders and Health Experts Gather in Yangon for First Regional Meeting on Corporate Sector Engagement in Malaria Control in the Asia-Pacific

(29 September, Yangon, Myanmar) More than 100 leaders from the health, development and corporate sectors have gathered in Yangon to participate in the seminal regional forum on Opportunities for Corporate Sector Engagement in Malaria Control in the Asia-Pacific. In advance of the 2015 enactment of the ASEAN Free Trade Agreement and broader ASEAN economic integration, this one-day meeting seeks to … Read More

Nisa PatelBusiness Leaders and Health Experts Gather in Yangon for First Regional Meeting on Corporate Sector Engagement in Malaria Control in the Asia-Pacific

Guide to 2014 UN General Assembly Side Events

The 69th session of the United Nations General Assembly (UNGA) will convene the week of September 22nd in New York City, drawing together government, business and health leaders from around the world. A prominent theme this year will be the Millennium Development Goals (MDGs)—eight targets that the global health community is working toward achieving by 2015, and the new Post-2015 Sustainable … Read More

Nisa PatelGuide to 2014 UN General Assembly Side Events

Eli Lilly: Searching for New Tuberculosis Drugs

Most TB drugs currently approved for treatment are 50+ years old and are required to be taken over a 6-month period to be effective. Compliance with such a long treatment regimen is a challenge, limiting drugs’ effectiveness and contributing to the rise in MDR-TB. As part of its MDR-TB Partnership, Eli Lilly and Company formed innovative partnerships with the Infectious … Read More

Nisa PatelEli Lilly: Searching for New Tuberculosis Drugs